EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1‐ Defining populations at risk

Armelle deLaforcade, Lenore Bacek iD, Marie-Claude Blais iD, Corrin Boyd iD, Benjamin M Brainard iD, Daniel L Chan iD, Stefano Cortellini, Robert Goggs iD, Guillaume L Hoareau iD, Amy Koenigshof, Ron Li iD, Alex Lynch iD and 3 more

Journal of Veterinary Emergency and Critical Care · 2022-05 · 32 (3) · 289-314

DOI: 10.1111/vec.13204 ↗

At a glance

Journal article in Journal of Veterinary Emergency and Critical Care, published online on 2022-05-02. Written by Armelle deLaforcade and 14 co-authors. Institution: Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts, USA. Major MEDLINE topics: Adrenocortical Hyperfunction, Anemia, Hemolytic, Autoimmune, Cat Diseases, Dirofilariasis. Cited 37 times so far (Crossref); 369 references. The full text is freely available (open access, CC BY 4.0). Funded by: NCATS NIH HHS.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Objectives

To expand the number of conditions and interventions explored for their associations with thrombosis in the veterinary literature and to provide the basis for prescribing recommendations.

Design

A population exposure comparison outcome format was used to represent patient, exposure, comparison, and outcome. Population Exposure Comparison Outcome questions were distributed to worksheet authors who performed comprehensive searches, summarized the evidence, and created guideline recommendations that were reviewed by domain chairs. The revised guidelines then underwent the Delphi survey process to reach consensus on the final guidelines. Diseases evaluated in this iteration included heartworm disease (dogs and cats), immune‐mediated hemolytic anemia (cats), protein‐losing nephropathy (cats), protein‐losing enteropathy (dogs and cats), sepsis (cats), hyperadrenocorticism (cats), liver disease (dogs), congenital portosystemic shunts (dogs and cats) and the following interventions: IV catheters (dogs and cats), arterial catheters (dogs and cats), vascular access ports (dogs and cats), extracorporeal circuits (dogs and cats) and transvenous pacemakers (dogs and cats).

Results

Of the diseases evaluated in this iteration, a high risk for thrombosis was defined as heartworm disease or protein‐losing enteropathy. Low risk for thrombosis was defined as dogs with liver disease, cats with immune‐mediated hemolytic anemia, protein‐losing nephropathy, sepsis, or hyperadrenocorticism.

Conclusions

Associations with thrombosis are outlined for various conditions and interventions and provide the basis for management recommendations. Numerous knowledge gaps were identified that represent opportunities for future studies.

Subjects

MeSH terms (MEDLINE)

Adrenocortical HyperfunctionAnemia, Hemolytic, AutoimmuneCat DiseasesDirofilariasisDog DiseasesProtein-Losing EnteropathiesSepsisThrombosisAnimalsCatsCritical CareDogsFibrinolytic AgentsRisk Factors

Author keywords

arrhythmiasheartworm diseaseprotein-losing enteropathyvascular devices

Substances

Fibrinolytic Agents

Authors and institutions

  • Department of Clinical Sciences, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts, USA.
  • Bluepearl Specialty and Emergency Pet Hospital, Tampa, Florida, USA.
  • Department of Clinical Sciences, University of Montreal, Saint-Hyacinthe, QC, Canada.
  • School of Veterinary Medicine, Murdoch University, Murdoch, Australia.
  • Department of Small Animal Medicine and Surgery, Clinical Sciences, University of Georgia, Athens, Georgia, USA.
  • Department of Clinical Science and Services, The Royal Veterinary College, London, UK.

ORCID profiles: Lenore Bacek, Marie-Claude Blais, Corrin Boyd, Benjamin M Brainard, Daniel L Chan, Robert Goggs, Guillaume L Hoareau, Ron Li, Alex Lynch, Elizabeth Rozanski

Funding

  • NCATS NIH HHS

Cite

APA

deLaforcade, A., Bacek, L., Blais, M. C., Boyd, C., Brainard, B. M., Chan, D. L., Cortellini, S., Goggs, R., Hoareau, G. L., Koenigshof, A., Li, R., Lynch, A., Ralph, A., Rozanski, E., & Sharp, C. R. (2022). 2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1‐ Defining populations at risk. Journal of Veterinary Emergency and Critical Care, 32(3), 289-314. https://doi.org/10.1111/vec.13204

Vancouver

deLaforcade A, Bacek L, Blais MC, Boyd C, Brainard BM, Chan DL, et al. 2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1‐ Defining populations at risk. Journal of Veterinary Emergency and Critical Care. 2022;32(3):289-314. doi:10.1111/vec.13204

BibTeX
@article{deLaforcade2022,
  author = {deLaforcade, Armelle and Bacek, Lenore and Blais, Marie-Claude and Boyd, Corrin and Brainard, Benjamin M and Chan, Daniel L and Cortellini, Stefano and Goggs, Robert and Hoareau, Guillaume L and Koenigshof, Amy and Li, Ron and Lynch, Alex and Ralph, Alan and Rozanski, Elizabeth and Sharp, Claire R},
  title = {2022 Update of the Consensus on the Rational Use of Antithrombotics and Thrombolytics in Veterinary Critical Care (CURATIVE) Domain 1‐ Defining populations at risk},
  journal = {Journal of Veterinary Emergency and Critical Care},
  year = {2022},
  volume = {32},
  number = {3},
  pages = {289--314},
  doi = {10.1111/vec.13204}
}
Start for free →